INOVIO PHARMACEUTICALS, INC. Derivative Liability
INOVIO PHARMACEUTICALS, INC. (INO) had Derivative Liability of $0 as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2020-11-09
- 2020-09-30: Derivative Liability $0.00.
- 2020-06-30: Derivative Liability $119.80M.
- 2020-03-31: Derivative Liability $22.04M.
- 2019-12-31: Derivative Liability $8.82M.
| Period end | Derivative Liability |
|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2020-06-30 | $119.80M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $22.04M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $8.82M 10-Q · filed 2020-11-09 |
| 2019-09-30 | $4.50M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |